AIP
ACER

Ameritas Investment Partners’s Acer Therapeutics Inc ACER Stock Holding History

Ameritas Investment Partners’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-443
Closed -$1K – 3164
2020
Q1 		$1K Hold
443
– – ﹤0.01% 3012
2019
Q4 		$2K Hold
443
– – ﹤0.01% 2985
2019
Q3 		$1K Hold
443
– – ﹤0.01% 3053
2019
Q2 		$2K Buy
+443
New +$8.44K ﹤0.01% 3028

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameritas Investment Partners's ACER Position: Q2 2020 in Review

Ameritas Investment Partners sold out of Acer Therapeutics Inc (ACER) in Q2 2020, closing a stake of 443 shares — an estimated $1K sold.

Ameritas Investment Partners first reported a position in ACER in Q2 2019 and held it in 4 quarters. The position peaked at $2K in Q4 2019. 34 funds tracked by Wall St. Rank hold ACER as of Q2 2020.

  • Ameritas Investment Partners reported no remaining Acer Therapeutics Inc position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Partners sold 443 Acer Therapeutics Inc shares in Q2 2020, an estimated $1K.
  • Ameritas Investment Partners first reported a position in Acer Therapeutics Inc in Q2 2019 and held it in 4 quarters.
  • Ameritas Investment Partners's Acer Therapeutics Inc position peaked at $2K in Q4 2019.
  • 34 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2020.

Based on Ameritas Investment Partners's 13F filing for Q2 2020, filed 5 Aug 2020.